Stoke Therapeutics STOK
Stoke Therapeutics: quarterly report
- Form
- 10-Q
- Filed
- Importance
- Notable
- Accession
- 0001564590-22-037497
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Trevi Therapeutics TRVI public float $588M, Jun 30, 2025
- Mersana Therapeutics MRSN
- Evolus EOLS public float $560M, Jun 30, 2025
- Xencor XNCR public float $556M, Jun 30, 2025
- Amphastar Pharmaceuticals AMPH public float $633M, Jun 30, 2025
